• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Activ Surgical closes $45M Series B funding round

Activ Surgical closes $45M Series B funding round

September 30, 2021 By Danielle Kirsh

activ surgicalActiv Surgical today announced that it has secured $45 million in a Series B funding round.

The funding round was led by Cota Capital and included seven new investors. To date, the Boston-based company has raised a total of $77 million.

Activ Surgical is developing a hardware-agnostic platform with ActivInsights augmented reality-based software for autonomous and collaborative surgery through computer vision, artificial intelligence, machine learning, AR and robotics.

The company has earmarked the funds from the Series B round to support the commercial availability of the ActivInsights software suite including the first Insight AR-based overlay that displays tissue perfusion in real-time without the need for traditional dyes. Activ Surgical also said it would use the funds to support commercialization in the U.S. and pursue a CE mark approval to support the global launch of the products.

As part of the fundraising round, Cota Capital partner Bobby Yazdani will join Activ Surgical’s board of directors. Yazdani has more than 30 years of entrepreneurial experience and more than 20 years of investing in technology companies.

“Activ Surgical is on pace to solve the ‘last mile’ challenge for the surgical field and revolutionize the operating room as we know it,” said Yazdani. “The company’s cutting-edge product portfolio, coupled with its talented and experienced leadership team and staff, has the potential to deliver world-class surgery, regardless of geography or economic status, while helping to save lives and reduce medical complications. We are thrilled to be the lead investor on this Series B fundraise and are excited about what the future holds for the company and its technology.”

CEO Todd Usen noted FDA clearance earlier this year of ActivSight, the company’s intraoperative imaging module for enhanced surgical visualization. The company also received its first U.S. patent for ActivSight, completed first in-human clinical trials and grew its team by 35%. (Usen discussed Activ Surgical’s work during a March 2021 DeviceTalks Weekly podcast.)

“The addition of seven new investors spanning the medical and technology industries is a wonderful testament to our team’s vision and work to date,” Usen said. “We are thrilled to be supported by this diverse group of investors, and we welcome Bobby to our board as we look to make our ActivInsights software suite commercially available in 2022.”

Filed Under: Business/Financial News, Featured, Funding Roundup, Surgical, Surgical Robotics Tagged With: Activ Surgical

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy